These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2161974)

  • 1. Control and oscillation in ligand receptor interactions according to the law of mass action.
    Tallarida RJ
    Life Sci; 1990; 46(22):1559-68. PubMed ID: 2161974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further characterization of a control model for ligand-receptor interaction: phase plane geometry, stability, and oscillation.
    Tallarida RJ
    Ann Biomed Eng; 1990; 18(6):671-84. PubMed ID: 2177963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control and stability of ligand receptor interaction in the presence of a competitive compound.
    Tallarida RJ; Freeman KA
    Life Sci; 1991; 48(6):PL19-24. PubMed ID: 1846933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chaos and control in mass-action binding of endogenous compounds.
    Tallarida RJ; Freeman KA
    Ann Biomed Eng; 1994; 22(2):153-61. PubMed ID: 7915503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of the combined contributions of agonist binding frequency and intrinsic efficiency to receptor-mediated activation of adenylate cyclase.
    Stickle D; Barber R
    Mol Pharmacol; 1991 Aug; 40(2):276-88. PubMed ID: 1678853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying biological activity in chemical terms: a pharmacology primer to describe drug effect.
    Kenakin T
    ACS Chem Biol; 2009 Apr; 4(4):249-60. PubMed ID: 19193052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KINFIT II: a nonlinear least-squares program for analysis of kinetic binding data.
    Rovati GE; Shrager R; Nicosia S; Munson PJ
    Mol Pharmacol; 1996 Jul; 50(1):86-95. PubMed ID: 8700124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-ligand interaction: a new method for determining binding parameters without a priori assumptions on non-specific binding.
    van Zoelen EJ
    Biochem J; 1989 Sep; 262(2):549-56. PubMed ID: 2553000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine ligand binding to cell receptors. Mathematical analysis of competition by solution "decoys".
    Forsten KE; Lauffenburger DA
    Biophys J; 1992 Feb; 61(2):518-29. PubMed ID: 1312367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo potency revisited - Keep the target in sight.
    Gabrielsson J; Peletier LA; Hjorth S
    Pharmacol Ther; 2018 Apr; 184():177-188. PubMed ID: 29024741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Partial' competition of heterobivalent ligand binding may be mistaken for allosteric interactions: a comparison of different target interaction models.
    Vauquelin G; Hall D; Charlton SJ
    Br J Pharmacol; 2015 May; 172(9):2300-15. PubMed ID: 25537684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interaction of the ligand molecules with the membrane receptors of tumor cells].
    Kaz'min SD
    Eksp Onkol; 1989; 11(2):25-8. PubMed ID: 2544393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.
    Ehlert FJ
    Mol Pharmacol; 1988 Feb; 33(2):187-94. PubMed ID: 2828914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two compartmental models for describing receptor ligand kinetics and receptor availability in multiple injection PET studies.
    Morris ED; Alpert NM; Fischman AJ
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):841-53. PubMed ID: 8784229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ligand-receptor-G-protein ternary complex as a GTP-synthase. steady-state proton pumping and dose-response relationships for beta -adrenoceptors.
    Broadley KJ; Nederkoorn PH; Timmerman H; Timms D; Davies RH
    J Theor Biol; 2000 Jul; 205(2):297-320. PubMed ID: 10873440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of receptor binding displacement curves by a nonhomologous ligand, on the basis of an equivalent competition principle.
    van Zoelen EJ
    Anal Biochem; 1992 Feb; 200(2):393-9. PubMed ID: 1321566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor binding kinetics equations: Derivation using the Laplace transform method.
    Hoare SRJ
    J Pharmacol Toxicol Methods; 2018; 89():26-38. PubMed ID: 28818556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curves of ligand binding. The use of hyperbolic functions for expressing titration curves.
    Dixon HB
    Biochem J; 1974 Mar; 137(3):443-7. PubMed ID: 4420319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-receptor interactions: detailed evaluation of occupancy-dependent affinity.
    Faguet GB
    J Cell Biochem; 1986; 31(1):75-86. PubMed ID: 3013909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequences of ligand bivalency in interactions involving particulate receptors: equilibrium and kinetic studies with Sephadex-concanavalin A, butylagarose-phosphorylase b, and Fc receptor-IgG dimer interactions as model systems.
    Hogg PJ; Reilly PE; Winzor DJ
    Biochemistry; 1987 Apr; 26(7):1867-73. PubMed ID: 2439115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.